Evaluation of Cardiac Biomarkers as Predictors of Short-Term Mortality Following Coronary Artery Bypass Grafting
Prima Abdillah Akbar1*, Yan Efrata Sembiring1, Oky Revianto Sediono Pribadi1, Puruhito1
Journal of Angiotherapy 8(12) 1-8 https://doi.org/10.25163/angiotherapy.81210091
Submitted: 18 December 2024 Revised: 18 December 2024 Published: 18 December 2024
Abstract
Background: Non-communicable diseases (NCDs), particularly cardiovascular diseases (CVDs) like coronary heart disease (CHD), are the leading cause of global mortality. Despite advancements in diagnostic and therapeutic interventions, CHD remains a significant healthcare challenge. Coronary artery bypass grafting (CABG) is a widely used surgical intervention for advanced CHD, but postoperative mortality remains a concern. Biomarkers such as N-terminal pro-brain natriuretic peptide (NT-proBNP), high-sensitivity troponin I (HS troponin I), and creatine kinase-myocardial band (CKMB) have been investigated for their prognostic value in predicting CABG outcomes, but their efficacy remains debated. Methods: This single-center retrospective cohort study, conducted at Soetomo General Academic Hospital, Surabaya, Indonesia, evaluated the relationship between preoperative levels of NT-proBNP, HS troponin I, and CKMB with 30-day post-CABG mortality. Participants undergoing CABG with cardiopulmonary bypass (CPB) between January and April 2024 were included. Data collected included biomarker levels (CK-MB, HS-TnI, NT-proBNP), CPB and cross-clamp times, and demographics. Statistical analysis was performed using logistic regression to assess associations with mortality. Results: A total of 31 participants (90.3% male, mean age 59.31 ± 9.11 years) were included. The biomarker levels were as follows: CK-MB (48.03 ± 41.28 U/L), NT-proBNP (875.33 ± 1253.73 pg/mL), and HS troponin I (5.17 ± 5.20 pg/mL). One mortality event (3.2%) occurred. Multivariate analysis showed no significant association between age, sex, or the biomarkers (CK-MB, HS troponin I, NT-proBNP) and mortality (p>0.05 for all). Conclusion: Preoperative levels of CK-MB, HS troponin I, and NT-proBNP were not significantly associated with short-term mortality following CABG in this study. These findings highlight the need for further research to explore additional clinical variables and biomarkers for improving mortality prediction in CABG patients.
Keywords: coronary artery bypass grafting, cardiac biomarkers, NT-proBNP, HS troponin I, mortality prediction
References
Beller, J. P., Hawkins, R. B., Mehaffey, J. H., LaPar, D. J., Kron, I. L., Yarboro, L. T., et al. (2018). Does preoperative troponin level impact outcomes after coronary artery bypass grafting? Annals of Thoracic Surgery, 106(1), 46-51.https://doi.org/10.1016/j.athoracsur.2018.01.085
Chua, T. K. T., Gao, F., Chia, S. Y., Sin, K. Y. K., Naik, M. J., Tan, T. E., & Tham, Y. C. (2024). Long-term mortality after isolated coronary artery bypass grafting and risk factors for mortality. Journal of Cardiothoracic Surgery, 19(1), 429. https://doi.org/10.1186/s13019-024-02943-0
Hess, N. R., Sultan, I., Wang, Y., Thoma, F. W., & Kilic, A. (2021). Preoperative troponin levels and outcomes of coronary surgery following myocardial infarction. Journal of Cardiac Surgery, 36(7), 2429-2439.https://doi.org/10.1111/jocs.15557
Jacob, R., & Khan, M. (2018). Cardiac biomarkers: What is and what can be. Indian Journal of Cardiovascular Disease in Women WINCARS, 3(4), 240-244.https://doi.org/10.1055/s-0039-1679104
Jawitz, O. K., Gulack, B. C., Brennan, J. M., Thibault, D. P., Wang, A., O'Brien, S. M., Schroder, J. N., Gaca, J. G., & Smith, P. K. (2020). Association of postoperative complications and outcomes following coronary artery bypass grafting. American Heart Journal, 222, 220–228. https://doi.org/10.1016/j.ahj.2020.02.002
Kementerian Kesehatan Republik Indonesia. (2017). Profil penyakit tidak menular tahun 2016. Kementerian Kesehatan Republik Indonesia. Retrieved from https://pusdatin.kemkes.go.id/article/view/17072400003/situasi-penyakit-lupus-di-indonesia.html
Lee, S. W., Lee, H., Kang, H., Choi, H., Chang, M., Roh, J. H., et al. (2016). Determinants and prognostic significance of periprocedural myocardial injury in patients with successful percutaneous chronic total occlusion interventions. Cardiovascular Intervention, 9(3), 315-323.https://doi.org/10.1016/j.jcin.2016.08.005
Machado, M. N., Rodrigues, F. B., Nakazone, M. A., Martin, D. F., Sabbag, A. T. R., Grigolo, I. H., et al. (2021). Prediction of death after noncardiac surgery: Potential advantage of using high-sensitivity troponin T as a continuous variable. Journal of the American Heart Association, 10(6), e019230.https://doi.org/10.1161/JAHA.120.018008
Miao, Z. L., Hou, A. J., Zang, H. Y., Huang, R. G., Zheng, X. Q., Lin, H. L., et al. (2017). Effects of recombinant human brain natriuretic peptide on the prognosis of patients with acute anterior myocardial infarction undergoing primary percutaneous coronary intervention: A prospective, multi-center, randomized clinical trial. Journal of Thoracic Disease, 9(1), 54-63.https://doi.org/10.21037/jtd.2017.01.15
Montrief, T., Koyfman, A., & Long, B. (2018). Coronary artery bypass graft surgery complications: A review for emergency clinicians. The American Journal of Emergency Medicine, 36(12), 2289–2297. https://doi.org/10.1016/j.ajem.2018.09.014
Neumann, F. J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., et al. (2019). 2018 ESC/EACTS guidelines on myocardial revascularization. European Heart Journal, 40(2), 87-165.https://doi.org/10.1093/eurheartj/ehy394
Paparella, D., Scrascia, G., Paramythiotis, A., Guida, P., Magari, V., Malvindi, P. G., et al. (2010). Prognostic value of high-sensitivity troponin T for long-term mortality after coronary artery bypass grafting. Heart, 96(15), 1150-1155.
Ralapanawa, U. N., & Sivakanesan, R. (2021). Trends in the incidence and prevalence of coronary heart disease in Sri Lanka. Journal of Cardiology & Current Research, 13(2), 78-85.
Vriints, P., Knaapen, P., & Janssens, S. (2024). Atherosclerosis and coronary heart disease: Mechanisms and treatment. Current Opinion in Cardiology, 39(1), 1-8.
Wu, C., Camacho, F. T., Wechsler, A. S., Lahey, S., Culliford, A. T., Jordan, D., Gold, J. P., Higgins, R. S., Smith, C. R., & Hannan, E. L. (2012). Predictors of early mortality following coronary artery bypass graft surgery. Journal of the American College of Cardiology, 60(7), 496–503.
Zhou, L., Yu, D., Zhang, Q., Sun, Y., Wang, Z., & Liu, X. (2023). Mortality predictors following coronary artery bypass grafting in patients with diabetes. Diabetes & Vascular Disease Research, 20(1), 52–58.
View Dimensions
View Altmetric
Save
Citation
View
Share